Data Strategy Consulting and AI Readiness for Life Sciences

A smart data strategy is essential for innovation, compliance, and performance. ProPharma's data strategy consulting services help life sciences organizations establish the trusted, governed, and discoverable data foundation required for AI, advanced analytics, and digital transformation.

Business professionals working with charts graphs at a table

Why Do You Need a Data Strategy?

A robust data strategy aligns data with business objectives, establishes effective governance and standards, and ensures information is trustworthy, accessible and fit for purpose. It provides the foundation for regulatory compliance, operational efficiency, digital transformation and AI adoption

Data Strategy Benefits

A well-defined data strategy helps life sciences organizations unlock greater value from their information assets while reducing risk and improving decision-making.
Innovation icon

Innovation and Efficiency

Optimized data collection, management and accessibility help organizations streamline operations, reduce inefficiencies and accelerate innovation across research,...

Read More

Innovation and Efficiency

Optimized data collection, management and accessibility help organizations streamline operations, reduce inefficiencies and accelerate innovation across research, development, manufacturing and clinical functions.

Read Less
Regulatory Sciences icon

Regulatory Compliance and Data Integrity

Life sciences organizations operate in highly regulated environments. Effective data governance, standards and stewardship support data integrity,...

Read More

Regulatory Compliance and Data Integrity

Life sciences organizations operate in highly regulated environments. Effective data governance, standards and stewardship support data integrity, traceability and regulatory compliance.

Read Less
Decentralized Clinical Trials icon

Better Decision-Making

Accessible, trustworthy and well-governed data enables faster, more informed decisions, helping organizations improve research outcomes, operational performance and patient...

Read More

Better Decision-Making

Accessible, trustworthy and well-governed data enables faster, more informed decisions, helping organizations improve research outcomes, operational performance and patient outcomes.

Read Less
Clinical technology services icon

Competitive Advantage 

Organizations that effectively manage and leverage their data are better positioned to identify opportunities, accelerate digital transformation and realize value from...

Read More

Competitive Advantage 

Organizations that effectively manage and leverage their data are better positioned to identify opportunities, accelerate digital transformation and realize value from analytics and AI initiatives.

Read Less
Service icon

Data Strategy for AI and AI Readiness

Many organizations are exploring AI but struggle with fragmented data, inconsistent definitions, poor discoverability or limited governance. A successful AI data...

Read More

Data Strategy for AI and AI Readiness

Many organizations are exploring AI but struggle with fragmented data, inconsistent definitions, poor discoverability or limited governance. A successful AI data strategy depends on trusted, accessible and well-managed information.

Our consultants help organizations perform an AI readiness assessment and establish the data foundations required to support advanced analytics, automation and AI adoption. This includes governance, data quality, metadata management, information architecture and change management.

Read Less
Webinar icon

FAIR Data, Metadata and Ontologies

Making data Findable, Accessible, Interoperable and Reusable (FAIR) is increasingly important for modern life sciences organizations. We help clients improve the...

Read More

FAIR Data, Metadata and Ontologies

Making data Findable, Accessible, Interoperable and Reusable (FAIR) is increasingly important for modern life sciences organizations. We help clients improve the discoverability and usability of their data through metadata management, controlled vocabularies, ontologies and data standards.

Our experience includes supporting industry initiatives and consortia, enabling organizations to create sustainable data foundations that support collaboration, regulatory requirements and future AI applications.

Read Less

How Can We Help With Your Data Strategy?

We support data strategy initiatives across R&D, clinical, regulatory, manufacturing and quality domains, including pharmaceutical, biotechnology and medical device settings.

Our Data Strategy Consulting service helps life sciences organizations establish the foundations required to manage, govern and derive value from their data. Combining deep scientific expertise with data and technology consulting experience, we help clients define practical strategies that align with business objectives and support future digital transformation initiatives.

We also help organizations design and govern data products that transform data into reusable business assets. Data products support reporting, analytics and AI use cases by making trusted, high-value information easier to access, understand and consume across the organization.

LRQA Certified ISO 9001 Logo
Professional workers collaborating in an office

Our Data Strategy Process

Start with a Digital Blueprint Assessment

Start with a Digital Blueprint Assessment

Data Maturity Assessment

Data Maturity Assessment

Data Strategy, Governance, and Standards

Data Strategy, Governance, and Standards

Use Cases

Use Cases

Start with a Digital Blueprint Assessment

Many organizations begin with a Digital Blueprint assessment to understand how data flows across the business and identify inefficiencies, silos and barriers to reuse. By examining the entire data lifecycle—from capture and creation through management, integration and reuse—we develop a blueprint for digital continuity that connects people, processes, data and technology. This helps organizations establish FAIR data principles at the source, improve data quality and discoverability, and make smarter investments in digital transformation and AI that are aligned to clear business outcomes.

Development team reviewing source code on computer monitors in an office.

Data Maturity Assessment

We assess your current data maturity against industry-wide definitions and use the findings to develop a practical data strategy roadmap. This helps prioritize the actions required to improve data management, governance and readiness for analytics and AI.

Professional reviewing business analytics dashboards across multiple monitors.

Data Strategy, Governance, and Standards

By establishing effective data strategy, governance and standards, organizations can improve trust in their data, reduce duplication and create a strong foundation for analytics, automation and AI. Clear ownership, policies and standards support better decision-making while ensuring alignment with business goals and regulatory requirements.

Technicians working in a data center

Use Cases

Use cases are essential considerations in defining the practical application of data, ensuring that insights align with your business objectives and drive measurable outcomes. By working with you to identify and implement clear use cases, your organization can prioritize data initiatives, optimize resource allocation, and enhance decision-making effectiveness.

Prioritised use cases help organisations focus investment on the right solutions for the right business problems. By clearly defining the desired outcomes, understanding the data required to support them and anticipating the process, behavioural and governance changes needed for adoption, organisations can maximise the value delivered by digital transformation, analytics and AI initiatives.

No matter where you are in your data strategy journey, ProPharma can help assess your current capabilities, identify opportunities for improvement and develop a practical roadmap for measurable business value.

No matter where you are in your data strategy journey, ProPharma can help assess your current capabilities, identify opportunities for improvement and develop a practical roadmap for measurable business value.

Data Strategy Thought Leadership

Digital Transformation First: Why AI Investment Depends on Strategy, Data, and Operational Readiness

Digital Transformation First: Why AI Investment Depends on Strategy, Data, and Operational Readiness

Our recent LinkedIn poll asked a simple question: What is the first step in a digital transformation journey? The response was decisive. Seventy percent of respondents identified strategy definition...

Digital Transformation in Life Sciences: The Importance of Data Strategy

Digital Transformation in Life Sciences: The Importance of Data Strategy

What is Digital Transformation? While there are many different definitions of digital transformation in life sciences, the core concepts they all have in common are digital technology and creating...

Defining and Implementing Global Data Standards & Governance

Defining and Implementing Global Data Standards & Governance

ProPharma has played a pivotal role in the implementation of scientific data standards and significantly contributed to the R&D-wide Data Standards & Governance program for a global biopharma with...

Virtual meeting or webinar on laptop

Webinar Replay: The Path to Clarity – Unlocking the Power of Data Standards for Digital Transformation

In today’s data-driven R&D landscape, organizations face a deluge of complex, siloed, and incompatible data that hinders innovation and slows progress.

This webinar explores how implementing robust data standards and governance frameworks can transform fragmented information into actionable intelligence. Led by experts from ProPharma and CSL  

 

Expert Data Strategy Consulting Services

Our data strategy consulting services help life sciences organizations establish the trusted data foundations required for innovation, compliance, digital transformation and AI adoption.

Our Data Strategy Consultants & Experts

  • Helen Lucke Bio Photo

    Helen Lucke

    Data Strategy Lead

    View Bio

  • Joost Van Kempen Bio Photo

    Joost Van Kempen

    Business Consultant

    View Bio

  • Pete Bament Bio Photo

    Pete Bament

    Business Consultant

    View Bio

  • Michael Burns Bio Photo

    Michael Burns

    Business Consultant

    View Bio

  • Kirsty Payne Bio Photo

    Kirsty Payne

    Business Consultant

    View Bio

  • Dana Vanderwall Bio Photo

    Dana Vanderwall

    Vice President, Digital Transformation

    View Bio

Helen Lucke is a  Data Strategy Lead  within ProPharma's Digital Transformation practice, specializing in data strategy, data governance, and scientific informatics for life sciences organizations. She helps clients improve the quality, management, and use of data to support regulatory compliance, operational efficiency, and digital transformation initiatives.

Joost is an experienced leader in providing strategies that help organizations improve their science through better utilization of technology and data. He has been instrumental in setting up and implementing data and digitization strategies in a diverse set of international settings across both industry and academia.

Pete is an experienced data leader with over 22 years of experience working across the pharmaceutical product lifecycle, from R&D to manufacturing. He has developed a broad knowledge base through personal experience and by working closely with partners in Quality, Technical, Production, Logistics, Finance, Clinical, Data, and IT functions.

Michael Burns has over 20 years of experience providing technical and business solutions to the pharmaceutical and biopharma R&D sector. He has experience in the Information Technology domain supporting, delivering, and managing IT solutions. He has also worked extensively as a consultant, delivering scientific software solutions, including Electronic Laboratory Notebooks, Data Management, Bioinformatics, and streamlining scientific workflows.

Mike has a proven track record of fostering understanding and collaboration across diverse groups of stakeholders.

Kirsty is a skilled technical project manager with over 20 years of experience in data management, software implementation, and data integrity management within regulatory environments, across the CRO and pharmaceutical sectors. She has a proven track record of driving process improvements, delivering training, and leading continuous enhancement initiatives.

Dana Vanderwall is an innovative leader in scientific solutions for drug discovery and digital transformation, with over 25 years of experience in pharmaceutical and biopharma R&D. He has experience in biochemistry, structural biology, computational chemistry, cheminformatics, IT, and data strategy in pharmaceutical R&D, as well as product management for enterprise informatics software. Dana has extensive experience providing an interface between IT and senior R&D leadership, responsible for the planning and delivery of informatics platforms, services, and tools in alignment with scientific goals and strategy. He has also led the strategy development and implementation of an R&D-wide metadata layer.

News & Insights

From Defensible to Predictive: How High-Functioning MLR Teams Are Evolving Their Risk Assessment Approach

October 21, 2026

From Defensible to Predictive: How High-Functioning MLR Teams Are Evolving Their...

Recent FDA enforcement activity is changing how MLR teams assess promotional risk. Learn why organizations are moving from defensible claims to predictive, enforcement-informed risk assessment.

AI-Readiness 101: AI Success Starts with Understanding Your Data

October 19, 2026

AI-Readiness 101: AI Success Starts with Understanding Your Data

Unlock AI success by understanding your data. Learn the foundations of AI readiness and how to build trust in your data for reliable insights.

What It Takes to Build a Successful Global Medical Information Program in Veterinary Medicine

October 13, 2026

What It Takes to Build a Successful Global Medical Information Program in Veteri...

Learn how to build a successful global medical information program in veterinary medicine, navigating complexity and enhancing customer support across diverse markets.

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Accelerating Clinical Trial Activation Across Latin America - ProPharma

October 20, 2026

Accelerating Clinical Trial Activation Across Latin America

Launching clinical trials across multiple countries requires navigating varying regulatory requirements, site contracts, translations, import/export processes, and site engagement activities, all...

Infographic Flexible Resourcing Without Limits: Scaling Capabilities Across the Development Lifecycle - ProPharma

September 18, 2026

Flexible Resourcing Without Limits: Scaling Capabilities Across the Development ...

Development complexity doesn’t increase in a straight line. As programs progress from discovery through Phase III, submission, and post-approval, demands for medical writing, biometrics, clinical...

Case Study Achieving Continuous Audit Readiness Across a Global Medical Information Program - ProPharma

August 3, 2026

Achieving Continuous Audit Readiness Across a Global Medical Information Program

Maintaining continuous audit readiness across a global Medical Information operation requires more than periodic audit preparation. Organizations operating across multiple countries and affiliates...

Beyond the Buzz: Leveraging Community Management to Enhance Medical Information

December 2, 2026

Beyond the Buzz: Leveraging Community Management to Enhance Medical Information

Patients, caregivers, and healthcare professionals are increasingly turning to digital channels to seek information, share experiences, and discuss treatments. Join this webinar to explore how...

Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

November 12, 2026

Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

Sites are being asked to do more than ever before while balancing increasing trial complexity, patient expectations, and operational demands. Join this webinar to explore how flexible, integrated...

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

October 22, 2026

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

Tired of working through lengthy regulatory documents? Join Reg Reels for a concise, video-led look at the latest pharmacovigilance developments from the EMA, FDA, and MHRA. Our experts will...

News & Insights

From Defensible to Predictive: How High-Functioning MLR Teams Are Evolving Their Risk Assessment Approach

October 21, 2026

From Defensible to Predictive: How High-Functioning MLR Teams Are Evolving Their...

Recent FDA enforcement activity is changing how MLR teams assess promotional risk. Learn why organizations are moving from defensible claims to predictive, enforcement-informed risk assessment.

AI-Readiness 101: AI Success Starts with Understanding Your Data

October 19, 2026

AI-Readiness 101: AI Success Starts with Understanding Your Data

Unlock AI success by understanding your data. Learn the foundations of AI readiness and how to build trust in your data for reliable insights.

What It Takes to Build a Successful Global Medical Information Program in Veterinary Medicine

October 13, 2026

What It Takes to Build a Successful Global Medical Information Program in Veteri...

Learn how to build a successful global medical information program in veterinary medicine, navigating complexity and enhancing customer support across diverse markets.

Previous Post Arrow Next Post Arrow
ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Accelerating Clinical Trial Activation Across Latin America - ProPharma

October 20, 2026

Accelerating Clinical Trial Activation Across Latin America

Launching clinical trials across multiple countries requires navigating varying regulatory requirements, site contracts, translations, import/export processes, and site engagement activities, all...

Infographic Flexible Resourcing Without Limits: Scaling Capabilities Across the Development Lifecycle - ProPharma

September 18, 2026

Flexible Resourcing Without Limits: Scaling Capabilities Across the Development ...

Development complexity doesn’t increase in a straight line. As programs progress from discovery through Phase III, submission, and post-approval, demands for medical writing, biometrics, clinical...

Case Study Achieving Continuous Audit Readiness Across a Global Medical Information Program - ProPharma

August 3, 2026

Achieving Continuous Audit Readiness Across a Global Medical Information Program

Maintaining continuous audit readiness across a global Medical Information operation requires more than periodic audit preparation. Organizations operating across multiple countries and affiliates...

Previous Resource Arrow Next Resource Arrow
Beyond the Buzz: Leveraging Community Management to Enhance Medical Information

December 2, 2026

Beyond the Buzz: Leveraging Community Management to Enhance Medical Information

Patients, caregivers, and healthcare professionals are increasingly turning to digital channels to seek information, share experiences, and discuss treatments. Join this webinar to explore how...

Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

November 12, 2026

Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

Sites are being asked to do more than ever before while balancing increasing trial complexity, patient expectations, and operational demands. Join this webinar to explore how flexible, integrated...

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

October 22, 2026

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

Tired of working through lengthy regulatory documents? Join Reg Reels for a concise, video-led look at the latest pharmacovigilance developments from the EMA, FDA, and MHRA. Our experts will...

Previous Webinar Arrow Next Webinar Arrow